| Outcome Measures: |
Primary: Changes from baseline in HbA1c (%), To evaluate changes in HbA1c from baseline one year after starting treatment with exenatide once weekly and basal insulin, one year post-index|Changes from baseline in weight (kg), To evaluate changes in weight (kg) from baseline one year after starting treatment with exenatide once weekly and basal insulin, one year post-index | Secondary: Frequency of hypoglycemia, to evaluate frequency of hypoglycemia in association with initiation of therapy with exenatide once weekly and basal insulin, one year post-index|Frequency of nausea, to evaluate frequency of nausea in association with initiation of therapy with exenatide once weekly and basal insulin, One year post-index|Frequency of vomiting, to evaluate frequency of vomiting in association with initiation of therapy with exenatide once weekly and basal insulin, one year post-index|Frequency of diarrhea and constipation, to evaluate frequency of diarrhea and constipation in association with initiation of therapy with exenatide once weekly and basal insulin, One year post-index
|
